THE PATHOLOGY, DIAGNOSIS, AND TREATMENT OF HEPATIC VENO‐OCCLUSIVE DISEASE: CURRENT STATUS AND NOVEL APPROACHES
Open Access
- 24 December 1999
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (3), 485-493
- https://doi.org/10.1046/j.1365-2141.1999.01680.x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantationBone Marrow Transplantation, 1997
- Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institutionBone Marrow Transplantation, 1997
- UTILITY OF TRANSVENOUS LIVER BIOPSIES AND WEDGED HEPATIC VENOUS PRESSURE MEASUREMENTS IN SIXTY MARROW TRANSPLANT RECIPIENTSTransplantation, 1995
- Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptomsHepatology, 1994
- Isolation and Identification of Aptamers from Defibrotide That Act as Thrombin Antagonists in VitroBiochemical and Biophysical Research Communications, 1994
- DefibrotideDrugs, 1993
- DefibrotideCardiovascular Drug Reviews, 1991
- Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamideCancer, 1988
- Effect of a New Antithrombotic Agent (Defibrotide) in Acute Renal Failure Due to Thrombotic MicroangiopathyNephron, 1985